当前位置: 首页 >> 检索结果
21. Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.
作者: Sankar D Navaneethan.;Sophia Zoungas.;M Luiza Caramori.;Juliana C N Chan.;Hiddo J L Heerspink.;Clint Hurst.;Adrian Liew.;Erin D Michos.;Wasiu A Olowu.;Tami Sadusky.;Nikhil Tandon.;Katherine R Tuttle.;Christoph Wanner.;Katy G Wilkens.;Jonathan C Craig.;David J Tunnicliffe.;Marcello Tonelli.;Michael Cheung.;Amy Earley.;Peter Rossing.;Ian H de Boer.;Kamlesh Khunti.
来源: Ann Intern Med. 2023年176卷3期381-387页
The KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease is an update of the 2020 guideline from Kidney Disease: Improving Global Outcomes (KDIGO).
22. Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians.
作者: Amir Qaseem.;Lauri A Hicks.;Itziar Etxeandia-Ikobaltzeta.;Tatyana Shamliyan.;Thomas G Cooney.; .;J Thomas Cross.;Nick Fitterman.;Jennifer S Lin.;Michael Maroto.;Adam J Obley.;Jeffrey A Tice.;Janice E Tufte.
来源: Ann Intern Med. 2023年176卷2期224-238页
This guideline updates the 2017 American College of Physicians (ACP) recommendations on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults.
23. The Management of Major Depressive Disorder: Synopsis of the 2022 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
作者: John R McQuaid.;Andrew Buelt.;Vincent Capaldi.;Matthew Fuller.;Fuad Issa.;Adam Edward Lang.;Charles Hoge.;David W Oslin.;James Sall.;Ilse R Wiechers.;Scott Williams.
来源: Ann Intern Med. 2022年175卷10期1440-1451页
In February 2022, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline (CPG) for the management of major depressive disorder (MDD). This synopsis summarizes key recommendations.
24. Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma.
作者: Lise J Estcourt.;Claudia S Cohn.;Monica B Pagano.;Claire Iannizzi.;Nina Kreuzberger.;Nicole Skoetz.;Elizabeth S Allen.;Evan M Bloch.;Gregory Beaudoin.;Arturo Casadevall.;Dana V Devine.;Farid Foroutan.;Thomas J Gniadek.;Ruchika Goel.;Jed Gorlin.;Brenda J Grossman.;Michael J Joyner.;Ryan A Metcalf.;Jay S Raval.;Todd W Rice.;Beth H Shaz.;Ralph R Vassallo.;Jeffrey L Winters.;Aaron A R Tobian.
来源: Ann Intern Med. 2022年175卷9期1310-1321页
Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a potential treatment of COVID-19. However, meta-analysis data and recommendations are limited. The Association for the Advancement of Blood and Biotherapies (AABB) developed clinical practice guidelines for the appropriate use of CCP.
25. Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians.
作者: Amir Qaseem.;Itziar Etxeandia-Ikobaltzeta.;Jennifer S Lin.;Nick Fitterman.;Tatyana Shamliyan.;Timothy J Wilt.; .;Carolyn J Crandall.;Thomas G Cooney.;J Thomas Cross.;Lauri A Hicks.;Michael Maroto.;Reem A Mustafa.;Adam J Obley.;Douglas K Owens.;Jeffrey Tice.;John W Williams.; .
来源: Ann Intern Med. 2022年175卷3期399-415页
The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the diagnosis and management of acute left-sided colonic diverticulitis in adults. This guideline is based on current best available evidence about benefits and harms, taken in the context of costs and patient values and preferences.
26. Colonoscopy for Diagnostic Evaluation and Interventions to Prevent Recurrence After Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians.
作者: Amir Qaseem.;Itziar Etxeandia-Ikobaltzeta.;Jennifer S Lin.;Nick Fitterman.;Tatyana Shamliyan.;Timothy J Wilt.; .;Carolyn J Crandall.;Thomas G Cooney.;J Thomas Cross.;Lauri A Hicks.;Michael Maroto.;Reem A Mustafa.;Adam J Obley.;Douglas K Owens.;Jeffrey Tice.;John W Williams.; .
来源: Ann Intern Med. 2022年175卷3期416-431页
The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the role of colonoscopy for diagnostic evaluation of colorectal cancer (CRC) after a presumed diagnosis of acute left-sided colonic diverticulitis and on the role of pharmacologic, nonpharmacologic, and elective surgical interventions to prevent recurrence after initial treatment of acute complicated and uncomplicated left-sided colonic diverticulitis. This guideline is based on the current best available evidence about benefits and harms, taken in the context of costs and patient values and preferences.
27. Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline.
作者: Charles R V Tomson.;Alfred K Cheung.;Johannes F E Mann.;Tara I Chang.;William C Cushman.;Susan L Furth.;Fan Fan Hou.;Gregory A Knoll.;Paul Muntner.;Roberto Pecoits-Filho.;Sheldon W Tobe.;Lyubov Lytvyn.;Jonathan C Craig.;David J Tunnicliffe.;Martin Howell.;Marcello Tonelli.;Michael Cheung.;Amy Earley.;Joachim H Ix.;Mark J Sarnak.
来源: Ann Intern Med. 2021年174卷9期1270-1281页
The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 clinical practice guideline for the management of blood pressure (BP) in patients with chronic kidney disease (CKD) not receiving dialysis is an update of the KDIGO 2012 guideline on the same topic and reflects new evidence on the risks and benefits of BP-lowering therapy among patients with CKD. It is intended to support shared decision making by health care professionals working with patients with CKD worldwide. This article is a synopsis of the full guideline.
28. Appropriate Use of High-Flow Nasal Oxygen in Hospitalized Patients for Initial or Postextubation Management of Acute Respiratory Failure: A Clinical Guideline From the American College of Physicians.
作者: Amir Qaseem.;Itziar Etxeandia-Ikobaltzeta.;Nick Fitterman.;John W Williams.;Devan Kansagara.; .;Pelin Batur.;Thomas G Cooney.;Carolyn J Crandall.;Lauri A Hicks.;Jennifer S Lin.;Michael Maroto.;Jeffrey Tice.;Janice E Tufte.;Sandeep Vijan.;John W Williams.
来源: Ann Intern Med. 2021年174卷7期977-984页
The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of high-flow nasal oxygen (HFNO) in hospitalized patients for initial or postextubation management of acute respiratory failure. It is based on the best available evidence on the benefits and harms of HFNO, taken in the context of costs and patient values and preferences.
29. Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emergency Department or Inpatient Settings: A Clinical Guideline From the American College of Physicians.
作者: Amir Qaseem.;Itziar Etxeandia-Ikobaltzeta.;Reem A Mustafa.;Devan Kansagara.;Nick Fitterman.;Timothy J Wilt.; .;Pelin Batur.;Thomas G Cooney.;Carolyn J Crandall.;Lauri A Hicks.;Jennifer S Lin.;Michael Maroto.;Jeffrey Tice.;Janice E Tufte.;Sandeep Vijan.;John W Williams.
来源: Ann Intern Med. 2021年174卷7期985-993页
The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of point-of-care ultrasonography (POCUS) in patients with acute dyspnea in emergency department (ED) or inpatient settings to improve the diagnostic, treatment, and health outcomes of those with suspected congestive heart failure, pneumonia, pulmonary embolism, pleural effusion, or pneumothorax.
30. Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians.
作者: Rachael A Lee.;Robert M Centor.;Linda L Humphrey.;Janet A Jokela.;Rebecca Andrews.;Amir Qaseem.; .;Elie A. Akl.;Thomas A. Bledsoe.;Mary Ann Forciea.;Ray Haeme.;Devan L. Kansagara.;Maura Marcucci.;Matthew C. Miller.;Adam J. Obley.
来源: Ann Intern Med. 2021年174卷6期822-827页
Antimicrobial overuse is a major health care issue that contributes to antibiotic resistance. Such overuse includes unnecessarily long durations of antibiotic therapy in patients with common bacterial infections, such as acute bronchitis with chronic obstructive pulmonary disease (COPD) exacerbation, community-acquired pneumonia (CAP), urinary tract infections (UTIs), and cellulitis. This article describes best practices for prescribing appropriate and short-duration antibiotic therapy for patients presenting with these infections.
31. What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1).
作者: Amir Qaseem.;Jennifer Yost.;Itziar Etxeandia-Ikobaltzeta.;Mary Ann Forciea.;George M Abraham.;Matthew C Miller.;Adam J Obley.;Linda L Humphrey.; .;Robert M Centor.;Elie A Akl.;Rebecca Andrews.;Thomas A Bledsoe.;Ray Haeme.;Devan L Kansagara.
来源: Ann Intern Med. 2021年174卷6期828-835页
The widespread availability of SARS-CoV-2 antibody tests raises important questions for clinicians, patients, and public health professionals related to the appropriate use and interpretation of these tests. The Scientific Medical Policy Committee (SMPC) of the American College of Physicians developed these rapid, living practice points to summarize the current and best available evidence on the antibody response to SARS-CoV-2 infection, antibody durability after initial infection with SARS-CoV-2, and antibody protection against reinfection with SARS-CoV-2.
32. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
作者: Amir Qaseem.;Jennifer Yost.;Itziar Etxeandia-Ikobaltzeta.;George M Abraham.;Janet A Jokela.;Mary Ann Forciea.;Matthew C Miller.;Linda L Humphrey.; .;Robert M. Centor.;Rebecca Andrews.;Ray Haeme.
来源: Ann Intern Med. 2021年174卷5期673-679页
Clinicians must have access to the best available evidence to inform point-of-care decisions about the use of remdesivir in patients with COVID-19. This article provides updated advice from the American College of Physicians for clinicians based on an updated rapid review.
33. Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline.
作者: Sankar D Navaneethan.;Sophia Zoungas.;M Luiza Caramori.;Juliana C N Chan.;Hiddo J L Heerspink.;Clint Hurst.;Adrian Liew.;Erin D Michos.;Wasiu A Olowu.;Tami Sadusky.;Nikhil Tandon.;Katherine R Tuttle.;Christoph Wanner.;Katy G Wilkens.;Lyubov Lytvyn.;Jonathan C Craig.;David J Tunnicliffe.;Martin Howell.;Marcello Tonelli.;Michael Cheung.;Amy Earley.;Peter Rossing.;Ian H de Boer.;Kamlesh Khunti.
来源: Ann Intern Med. 2021年174卷3期385-394页
The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2020 for the management of patients with diabetes and chronic kidney disease (CKD).
34. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1).
作者: Amir Qaseem.;Jennifer Yost.;Itziar Etxeandia-Ikobaltzeta.;George M Abraham.;Janet A Jokela.;Mary Ann Forciea.;Matthew C Miller.;Linda L Humphrey.; .;Robert M Centor.;Rebecca Andrews.;Ray Haeme.;Devan L Kansagara.;Maura Marcucci.
来源: Ann Intern Med. 2021年174卷2期229-236页
These rapid and living practice points from the American College of Physicians address the effectiveness and harms of remdesivir treatment in patients with COVID-19.
35. Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel.
作者: Alice K Pau.;Judith Aberg.;Jason Baker.;Pamela S Belperio.;Craig Coopersmith.;Page Crew.;Birgit Grund.;Roy M Gulick.;Carly Harrison.;Arthur Kim.;H Clifford Lane.;Henry Masur.;Virginia Sheikh.;Kanal Singh.;Jinoos Yazdany.;Pablo Tebas.; .
来源: Ann Intern Med. 2021年174卷1期93-95页
In the United States, the efficacy and safety of convalescent plasma for treating coronavirus disease 2019 (COVID-19) is currently being tested in randomized placebo-controlled clinical trials. Treatment of individual patients with COVID-19 with convalescent plasma outside such trials is also now permitted through U.S. Food and Drug Administration Emergency Use Authorization. Here, members of the National Institutes of Health COVID-19 Treatment Guidelines Panel provide their views regarding use of convalescent plasma for treating COVID-19.
36. Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
作者: Patrick G O'Malley.;Michael J Arnold.;Cathy Kelley.;Lance Spacek.;Andrew Buelt.;Sundar Natarajan.;Mark P Donahue.;Elena Vagichev.;Jennifer Ballard-Hernandez.;Amanda Logan.;Lauren Thomas.;Joan Ritter.;Brian E Neubauer.;John R Downs.
来源: Ann Intern Med. 2020年173卷10期822-829页
In June 2020, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) released a joint update of their clinical practice guideline for managing dyslipidemia to reduce cardiovascular disease risk in adults. This synopsis describes the major recommendations.
37. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.
作者: Marie E Faughnan.;Johannes J Mager.;Steven W Hetts.;Valerie A Palda.;Kelly Lang-Robertson.;Elisabetta Buscarini.;Erik Deslandres.;Raj S Kasthuri.;Andrea Lausman.;David Poetker.;Felix Ratjen.;Mark S Chesnutt.;Marianne Clancy.;Kevin J Whitehead.;Hanny Al-Samkari.;Murali Chakinala.;Miles Conrad.;Daniel Cortes.;Claudia Crocione.;Jama Darling.;Els de Gussem.;Carol Derksen.;Sophie Dupuis-Girod.;Patrick Foy.;Urban Geisthoff.;James R Gossage.;Adrienne Hammill.;Ketil Heimdal.;Katharine Henderson.;Vivek N Iyer.;Anette D Kjeldsen.;Masaki Komiyama.;Kevin Korenblatt.;Jamie McDonald.;Jack McMahon.;Justin McWilliams.;Mary E Meek.;Meir Mei-Zahav.;Scott Olitsky.;Sara Palmer.;Rose Pantalone.;Jay F Piccirillo.;Beth Plahn.;Mary E M Porteous.;Marco C Post.;Ivan Radovanovic.;Paul J Rochon.;Josanna Rodriguez-Lopez.;Carlo Sabba.;Marcelo Serra.;Claire Shovlin.;Dennis Sprecher.;Andrew J White.;Ingrid Winship.;Roberto Zarrabeitia.
来源: Ann Intern Med. 2020年173卷12期989-1001页
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease with an estimated prevalence of 1 in 5000 that is characterized by the presence of vascular malformations (VMs). These result in chronic bleeding, acute hemorrhage, and complications from shunting through VMs. The goal of the Second International HHT Guidelines process was to develop evidence-based consensus guidelines for the management and prevention of HHT-related symptoms and complications.
38. Synopsis of the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: The Diagnosis and Management of Hypertension in the Primary Care Setting.
作者: Cdr Mark P Tschanz.;William C Cushman.;Cdr Travis E Harrell.;Dan R Berlowitz.;James L Sall.
来源: Ann Intern Med. 2020年173卷11期904-913页
In January 2020, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the diagnosis and management of hypertension in the primary care setting.
39. Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline.
作者: Kacie Doyle-Delgado.;James J Chamberlain.;Jay H Shubrook.;Neil Skolnik.;Jennifer Trujillo.
来源: Ann Intern Med. 2020年173卷10期813-821页
The American Diabetes Association (ADA) updates the Standards of Medical Care in Diabetes annually to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and management of diabetes.
40. Nonpharmacologic and Pharmacologic Management of Acute Pain From Non-Low Back, Musculoskeletal Injuries in Adults: A Clinical Guideline From the American College of Physicians and American Academy of Family Physicians.
作者: Amir Qaseem.;Robert M McLean.;David O'Gurek.;Pelin Batur.;Kenneth Lin.;Devan L Kansagara.; .; .;Thomas G Cooney.;Mary Ann Forciea.;Carolyn J Crandall.;Nick Fitterman.;Lauri A Hicks.;Carrie Horwitch.;Michael Maroto.;Robert M McLean.;Reem A Mustafa.;Janice Tufte.;Sandeep Vijan.;John W Williams.
来源: Ann Intern Med. 2020年173卷9期739-748页
The American College of Physicians (ACP) and American Academy of Family Physicians (AAFP) developed this guideline to provide clinical recommendations on nonpharmacologic and pharmacologic management of acute pain from non-low back, musculoskeletal injuries in adults in the outpatient setting. The guidance is based on current best available evidence about benefits and harms, taken in the context of costs and patient values and preferences. This guideline does not address noninvasive treatment of low back pain, which is covered by a separate ACP guideline that has also been endorsed by AAFP.
|